Carcinoid syndrome.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001079:Apudoma / Q000175:diagnosis; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000628:therapy; D003533:Cyproheptadine / Q000627:therapeutic use; D010134:Fenclonine / Q000627:therapeutic use; D005769:Gastrointestinal Motility; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis* / Q000628:therapy; D008750:Methyldopa / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012701:Serotonin / Q000097:blood
D000970:Antineoplastic Agents; D010643:Phenoxybenzamine; D003533:Cyproheptadine; D012701:Serotonin; D008750:Methyldopa; D010134:Fenclonine; D008784:Methysergide